Dyne Therapeutics, Inc. Common Stock earnings per share and revenue
On Jan 12, 2026, DYN reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.77 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.41% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 9 analysts forecast an EPS of -0.82 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Dyne Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Dyne Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Dyne Therapeutics, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -2.41%, changed from $17.46 before the earnings release to $17.04 the day after.
When is Dyne Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Dyne Therapeutics, Inc. Common Stock's next earnings report?
Based on 9
analysts, Dyne Therapeutics, Inc. Common Stock is expected to report EPS of -$0.82 and revenue of -- for Q1 2026.